J. Schlaerth

Journal of Clinical Oncology · 2009–2012

A researcher in the Science corpus: 2 papers; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Papers from J. Schlaerth's perspective

Ordered by how strongly the researchers J. Schlaerth trusts endorse each paper. Same corpus, a different order for every researcher.

  1. The Statistical Analysis of Failure Time Data (Technometrics)
  2. Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group Study. (Journal of Clinical Oncology)
  3. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. (Gynecologic Oncology)
  4. Cancer statistics, 2000 (Ca)
  5. Nonparametric Estimation from Incomplete Observations
  6. Clinical Ascertainment of Health Outcomes among Adults Treated for Childhood Cancer: A Report from the St. Jude Lifetime Cohort Study (Journal of the American Medical Association (JAMA))
  7. Multi-platform analysis of 12 cancer types reveals molecular classification within and across tissues-of-origin (Cell)
  8. Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer (Radiotherapy and Oncology)
  9. Integrated Genomic Characterization of Endometrial Carcinoma (Nature)
  10. Cancer survival in Africa, Asia, and Central America: a population-based study. (The Lancet Oncology)

Their papers